AGEAS

HEALTH CHECK

16/05/24 -"As we have consistently argued over the last 3 years, Health stocks (ex Pharma) are long on growth promises and short on delivery. The gap stems from the fact that delivery hinges on buying the next ..."

PDF page sample
Pages
45
Language
English
Published on
16/05/24
Download
You may also be interested by these reports :
11/07/25
We have raised our forecasts for Storebrand following the release of stronger-than-expected 2Q25 results. The main positive surprise came from the ...
11/07/25
Storebrand delivered strong 2Q25 results, beating expectations. The result before amortisation and write-downs reached NOK 1,427m, 15% ahead of ...
02/07/25
Despite a respectable performance, Legal & General (ADD; UK) has underperformed its peers in the insurance sector over the last couple of years, as ...
18/06/25
During its Asset Management deep dive, Legal & General reiterated the FY28 targets for the division, originally set at last June’s Capital Markets ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO